With this concept in mind, we prospectively assessed thyroid status (thyroid function, autoimmunity and ultrasound features) in a cohort of HCV patients, subdivided in naïve and previously treated with IFN-α and ribavirin, before and after DAAs therapy. The gene discussed is IFNA17; the disease is Autoimmunity.